GPT and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Overall, female dysferlinopathy patients displayed lower ALT (by 32%; p < 0.0001) and AST (by 22%; p < 0.001) levels than males (Figure 6A,B).